dostarlimab,cobolimab,nivolumab
bms,gsk
['nivo', 'dostarlimab', 'cobolimab', 'melanoma']
amber: a phase i trial of cobolimab (a tim-3 inhibitor) +/- nivo or dostarlimab (anti-pd-1)--&gt; manageable safety profile; dlts diarrhea, ast/alt, lipase elevation. preliminary efficacy data is encouraging esp in pts with melanoma #asco22 
Assistant Prof | Thoracic Oncology & Phase-I  @karmanoscancer | Previously @MayoCancerCare @gundersenhealth @JeffHealthAb @bpkihsofficial | Views/Tweets my own